Arkolith/Insider Trading/MBX/Form 4

OrbiMed Genesis GP LLC

Director, 10% OwnerMBX Biosciences, Inc. (MBX) · full profile →Form 4 · filed Feb 19, 2025
Net Buying
Open-Market Buys
$2.0M
Open-Market Sells
$0
Net Open-Market Flow
$2.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2025Buy(P)94K$10.84$1.0M748K
Feb 18, 2025Buy(P)49K$10.84$532K3.3M
Feb 14, 2025Buy(P)18K$9.90$178K3.2M
Feb 14, 2025Buy(P)30K$9.85$291K3.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-25-000199) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML